Board/Management Information • Aug 12, 2025
Board/Management Information
Open in ViewerOpens in native device viewer
REIT 1 LTD
Registration Number: 513821488
To: Securities Authority To: Tel Aviv Stock Exchange Ltd. Form Number: T093 (Public) Sent via MAGNA: 12/08/2025 www.isa.gov.il www.tase.co.il Reference: 2025-01-059593
Regulation 34(b) of the Securities Regulations (Periodic and Immediate Reports), 1970
Explanation: According to Regulation 34(d) of the Securities Regulations (Periodic and Immediate Reports), 1970, a list of senior office holders must be submitted concurrently with this form as part of Form T097.
Assaf Segal
Name in English as appears in passport: Assaf Segal
Gender: Male
Type of Identification Number: ID Number
Identification Number: 028756849
Citizenship: Private individual with Israeli citizenship Country of Citizenship: _________
22/11/1971
Menachem Begin 132, Azrieli Towers, Triangle Tower, Tel Aviv
| Position | Description | ||
|---|---|---|---|
| External Director |
___ |
If appointed as Chairman of the Board, is he also the CEO or a relative of the CEO: _________
Appointment approved at the general meeting on: _________
If appointed as Chairman of the Board, does he hold additional positions in the company:
Details: _________
_________
| Previous Position |
Description | ||
|---|---|---|---|
| None | ___ |
12/08/2025
| Degree | Field | Academic Institution |
|---|---|---|
| Master's | Business Administration |
The Hebrew University of Jerusalem |
| Bachelor's | Economics and Statistics |
The Hebrew University of Jerusalem |
Other education and professional certificates: _________
| Position | Workplace | ID Number Type |
ID Number |
Duration |
|---|---|---|---|---|
| CEO | CLAL BIOTECHNOLOGY INDUSTRIES LTD |
Company number in Israel |
511898835 | Nov 2022 - Jan 2024 |
| Acting CEO |
CLAL BIOTECHNOLOGY INDUSTRIES LTD |
Company number in Israel |
511898835 | Jun 2022 - Oct 2022 |
| CFO | CLAL BIOTECHNOLOGY INDUSTRIES LTD |
Company number in Israel |
511898835 | Jul 2015 - Oct 2022 |
Explanation: To be filled if appointed as an alternate director.
Explanation: If he serves as a director in another corporation, specify the corporations where he serves as a director.
Biokin Therapeutics Ltd.
Explanation: If an employee of the corporation or a subsidiary or related company or of an interested party, specify the positions held as such.
Explanation: If the director is a family member of another interested party in the corporation, specify.
Below is the list of his holdings:
| Name, Type, and Series of Security |
Security Number on Exchange |
Quantity of Securities |
Dormant | Holding Percentage (Equity) |
Holding Percentage (Voting) |
Holding Percentage (Fully Diluted Equity) |
Holding Percentage (Fully Diluted Voting) |
|---|---|---|---|---|---|---|---|
| ___ | ___ | ___ | ___ | ___ | ___ | ___ | ___ |
b. The Director does not hold securities of a held company of the reporting corporation if its activity is material to the activity of the reporting corporation.
Below is the list of his holdings:
| Corporation Number |
Corporation Name |
Corporation Name (English) |
Type of Identification Number |
Corporation Identification Number |
|---|---|---|---|---|
| 1 | ___ | ___ | ___ | ___ |
Explanation: If the director is a member of a committee or committees of the board, specify.
Audit Committee, Financial Statements Review Committee, Compensation Committee
How did he become independent: Appointed by the general meeting, on: 07/08/2025
2025_Assaf_Segal_isa.pdf
Explanation: Attaching the director's declaration is required even if the director's appointment was not made by the general meeting.
| # | Name | Position | Additional Description |
|---|---|---|---|
| 1 | Shmuel Rofeh |
CEO | ___ |
| 2 | Aviram Benasouli |
CFO | ___ |
Explanation: According to Regulation 5 of the Periodic and Immediate Reports Regulations (1970), a report submitted under these regulations must be signed by those authorized to sign on behalf of the corporation. The staff's position on the matter can be found on the Authority's website: Click here.
Securities of the corporation are listed for trading on the Tel Aviv Stock Exchange
Form structure update date: 06/08/2024
Short Name: REIT 1 LTD
Address: 6 Nehoshet St., Tel Aviv 69710 Phone: 03-7686700, Fax: 03-7686710 Email: [email protected] Company website: www.Reit1.co.il
Previous names of the reporting entity:
Electronic reporter name: Guy Viskopf Position: Accountant Employer company name: -
Address: 6 Nehoshet St., Tel Aviv 69710 Phone: 03-7686700, Fax: 03-7686710 Email: [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.